Jonathan D. Douros

1.9k total citations · 1 hit paper
27 papers, 1.1k citations indexed

About

Jonathan D. Douros is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, Jonathan D. Douros has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Physiology and 10 papers in Molecular Biology. Recurrent topics in Jonathan D. Douros's work include Diabetes Treatment and Management (14 papers), Diet and metabolism studies (8 papers) and Regulation of Appetite and Obesity (8 papers). Jonathan D. Douros is often cited by papers focused on Diabetes Treatment and Management (14 papers), Diet and metabolism studies (8 papers) and Regulation of Appetite and Obesity (8 papers). Jonathan D. Douros collaborates with scholars based in United States, Denmark and Germany. Jonathan D. Douros's co-authors include David A. D’Alessio, Jonathan E. Campbell, Jenny Tong, Kyle W. Sloop, Megan E. Capozzi, Russell J. Borski, Francis S. Willard, David B. Wainscott, Paul J. Emmerson and Wijnand J. C. van der Velden and has published in prestigious journals such as PLoS ONE, Endocrine Reviews and Cell Metabolism.

In The Last Decade

Jonathan D. Douros

25 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

2020 314 citations Francis S. Willard, Jonathan D. Douros et al. JCI Insight profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan D. Douros United States	15	561	429	354	325	195	27	1.1k
Jean‐François Louet United States	16	280 0.5×	733 1.7×	406 1.1×	205 0.6×	249 1.3×	19	1.4k
Wenying Quan South Korea	14	130 0.2×	323 0.8×	235 0.7×	363 1.1×	656 3.4×	17	1.1k
Rebecca Quinn United States	5	144 0.3×	781 1.8×	549 1.6×	237 0.7×	207 1.1×	8	1.2k
Bilal Omar Sweden	15	323 0.6×	390 0.9×	201 0.6×	284 0.9×	105 0.5×	22	842
Tristan J. Iseli Australia	15	294 0.5×	880 2.1×	270 0.8×	400 1.2×	389 2.0×	16	1.4k
F. Andreelli France	12	232 0.4×	644 1.5×	362 1.0×	228 0.7×	231 1.2×	16	1.0k
Meriem Semache Canada	14	374 0.7×	582 1.4×	369 1.0×	587 1.8×	142 0.7×	21	1.2k
Larissa Atangan United States	10	312 0.6×	408 1.0×	220 0.6×	156 0.5×	123 0.6×	12	852
Sheene Kim United States	10	227 0.4×	879 2.0×	862 2.4×	248 0.8×	427 2.2×	11	1.5k
Lena Stenson Holst Sweden	18	200 0.4×	688 1.6×	367 1.0×	385 1.2×	66 0.3×	20	1.2k

Countries citing papers authored by Jonathan D. Douros

Since Specialization

Citations

This map shows the geographic impact of Jonathan D. Douros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan D. Douros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan D. Douros more than expected).

Fields of papers citing papers by Jonathan D. Douros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan D. Douros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan D. Douros. The network helps show where Jonathan D. Douros may publish in the future.

Co-authorship network of co-authors of Jonathan D. Douros

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan D. Douros. A scholar is included among the top collaborators of Jonathan D. Douros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan D. Douros. Jonathan D. Douros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Douros, Jonathan D., Ronald Goldwater, Ann Maria Kruse Hansen, et al.. (2025). A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans. Molecular Metabolism. 96. 102129–102129. 6 indexed citations

Richard, Jennifer E., Andrew McGovern, Stephanie E. Lieblich, et al.. (2025). Sex-specific metabolic and central effects of GLP-1–estradiol conjugate in middle-aged rats on a standard or western diet. Brain Behavior and Immunity. 130. 106088–106088.

Sun, Na, Ahmed Khalil, Arkadiusz Liśkiewicz, et al.. (2025). Estrogenic activity of E2-conjugated GLP-1 is mediated by intracellular endolysosomal acidification and estrone metabolism. Molecular Metabolism. 96. 102136–102136. 1 indexed citations

Douros, Jonathan D., Jonathan N. Flak, & Patrick J. Knerr. (2025). The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP. Frontiers in Endocrinology. 16. 1530985–1530985. 7 indexed citations

Parikh, Mihir, Seyed Ali Ziai, Chuck T. Chen, et al.. (2025). Acute exogenous acyl-GIP treatment enhances lipid handling and fatty acid oxidation by involving brown fat. EMBO Reports. 26(21). 5154–5171. 2 indexed citations

Lima, Natália da Silva, Eva Nóvoa, Cristina Riobello, et al.. (2024). GLP-1 and GIP agonism has no direct actions in human hepatocytes or hepatic stellate cells. Cellular and Molecular Life Sciences. 81(1). 468–468. 9 indexed citations

Wunderlich, M, Ronan Le Gleut, Patrick J. Knerr, et al.. (2024). Experimental colonization with H. hepaticus, S. aureus and R. pneumotropicus does not influence the metabolic response to high-fat diet or incretin-analogues in wildtype SOPF mice. Molecular Metabolism. 87. 101992–101992.

El, Kimberley, Jonathan D. Douros, Francis S. Willard, et al.. (2023). The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets. Nature Metabolism. 5(6). 945–954. 74 indexed citations

Chandra, Rashmi, Dipendra K. Aryal, Jonathan D. Douros, et al.. (2022). Ildr1 gene deletion protects against diet-induced obesity and hyperglycemia. PLoS ONE. 17(6). e0270329–e0270329. 2 indexed citations

10.

Yang, Bin, Vasily M. Gelfanov, Kimberley El, et al.. (2022). Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems. Molecular Metabolism. 66. 101638–101638. 34 indexed citations

11.

Willard, Francis S., Jonathan D. Douros, M Gabe, et al.. (2020). Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight. 5(17). 314 indexed citations breakdown →

12.

Mankiewicz, Jamie L., et al.. (2020). Epinephrine and glucose regulation of leptin synthesis and secretion in a teleost fish, the tilapia (Oreochromis mossambicus). General and Comparative Endocrinology. 302. 113669–113669. 14 indexed citations

13.

Capozzi, Megan E., Inna Astapova, Jonathan D. Douros, et al.. (2020). The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition. Diabetes. 69(5). 882–892. 50 indexed citations

14.

Douros, Jonathan D., Jingjing Niu, Sophia M. Sdao, et al.. (2019). Sleeve gastrectomy rapidly enhances islet function independently of body weight. JCI Insight. 4(6). 30 indexed citations

15.

Douros, Jonathan D., Jingjing Niu, Sophia M. Sdao, et al.. (2019). Temporal plasticity of insulin and incretin secretion and insulin sensitivity following sleeve gastrectomy contribute to sustained improvements in glucose control. Molecular Metabolism. 28. 144–150. 10 indexed citations

16.

Douros, Jonathan D., David A. Baltzegar, Benjamin J. Reading, et al.. (2018). Leptin Stimulates Cellular Glycolysis Through a STAT3 Dependent Mechanism in Tilapia. Frontiers in Endocrinology. 9. 465–465. 27 indexed citations

17.

Anderson, Kristin A., Frank K. Huynh, Kelsey H. Fisher‐Wellman, et al.. (2017). SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin Secretion. Cell Metabolism. 25(4). 838–855.e15. 256 indexed citations

18.

Douros, Jonathan D., David A. Baltzegar, Jamie L. Mankiewicz, et al.. (2016). Control of leptin by metabolic state and its regulatory interactions with pituitary growth hormone and hepatic growth hormone receptors and insulin like growth factors in the tilapia ( Oreochromis mossambicus ). General and Comparative Endocrinology. 240. 227–237. 37 indexed citations

19.

Won, Eugene, et al.. (2016). Leptin stimulates hepatic growth hormone receptor and insulin-like growth factor gene expression in a teleost fish, the hybrid striped bass. General and Comparative Endocrinology. 229. 84–91. 32 indexed citations

20.

Douros, Jonathan D., David A. Baltzegar, Jason P. Breves, et al.. (2014). Prolactin is a major inhibitor of hepatic Leptin A synthesis and secretion: Studies utilizing a homologous Leptin A ELISA in the tilapia. General and Comparative Endocrinology. 207. 86–93. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact